GK Partners ApS - 30 Aug 2024 Form 4 Insider Report for Nordicus Partners Corp (NORD)

Role
10%+ Owner
Signature
/s/ Tom Glaesner Larsen
Issuer symbol
NORD
Transactions as of
30 Aug 2024
Transactions value $
$311,000
Form type
4
Filing time
10 Dec 2024, 14:04:37 UTC
Previous filing
23 Aug 2024
Next filing
14 Oct 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NORD Common stock Purchase $5,000 +500 +0.02% $10 2,245,956 03 Sep 2024 Direct
transaction NORD Common stock Purchase $50,000 +5,000 +0.22% $10 2,250,956 01 Oct 2024 Direct
transaction NORD Common stock Other +1,076,412 +47.35% 3,349,568 12 Nov 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NORD Warrant Exercise of out-of-the-money derivative security $34,000 +3,400 +0.64% $10 532,500 30 Aug 2024 Common stock 600,000 $10 Direct
transaction NORD Warrant Exercise of out-of-the-money derivative security $32,000 +3,200 +0.61% $10 529,300 03 Oct 2024 Common stock 600,000 $10 Direct
transaction NORD Warrant Exercise of out-of-the-money derivative security $120,000 +12,000 +2.37% $10 517,300 17 Oct 2024 Common stock 600,000 $10 Direct
transaction NORD Warrant Exercise of out-of-the-money derivative security $35,000 +3,500 +0.69% $10 513,800 01 Nov 2024 Common stock 600,000 $10 Direct
transaction NORD Warrant Exercise of out-of-the-money derivative security $35,000 +3,500 +0.69% $10 510,300 06 Nov 2024 Common stock 600,000 $10 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired in connection with the acquisition by Nordicus Partners Corporation through a share exchange with the shareholders of Bio-Convert ApS (893,268 shares) and in connection with the acquisition by Nordicus Partners Corporation of Orocidin A/S (183,144 shares) on November 12, 2024.